RIZZI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 3.267
NA - Nord America 2.699
AS - Asia 2.253
SA - Sud America 182
AF - Africa 48
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.477
Nazione #
US - Stati Uniti d'America 2.605
GB - Regno Unito 972
IT - Italia 748
CN - Cina 746
SG - Singapore 637
DE - Germania 351
RU - Federazione Russa 287
SE - Svezia 287
HK - Hong Kong 196
FR - Francia 145
VN - Vietnam 145
TR - Turchia 119
BR - Brasile 109
IN - India 109
KR - Corea 105
NL - Olanda 105
UA - Ucraina 103
BD - Bangladesh 86
IE - Irlanda 67
FI - Finlandia 63
CA - Canada 61
EU - Europa 52
BE - Belgio 32
CO - Colombia 31
JP - Giappone 27
ID - Indonesia 26
CI - Costa d'Avorio 24
MX - Messico 18
ES - Italia 17
GR - Grecia 17
AR - Argentina 13
NZ - Nuova Zelanda 12
PL - Polonia 12
IQ - Iraq 10
AU - Australia 9
ZA - Sudafrica 9
CL - Cile 8
PH - Filippine 8
VE - Venezuela 8
AT - Austria 7
CZ - Repubblica Ceca 7
AL - Albania 6
CH - Svizzera 6
KE - Kenya 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
EC - Ecuador 5
MY - Malesia 5
RO - Romania 5
DK - Danimarca 4
NO - Norvegia 4
PT - Portogallo 4
CR - Costa Rica 3
JM - Giamaica 3
NI - Nicaragua 3
PE - Perù 3
PK - Pakistan 3
RS - Serbia 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 8.524
Città #
Southend 858
Singapore 362
Ashburn 249
Chandler 233
Milan 223
Hong Kong 187
Beijing 158
San Jose 140
Seattle 136
Ann Arbor 134
Princeton 98
Fairfield 83
Jacksonville 78
Wilmington 71
Dearborn 69
Council Bluffs 68
Dublin 67
Santa Clara 66
Boardman 62
Woodbridge 61
Nanjing 59
Dallas 58
Munich 58
Los Angeles 57
Mountain View 54
Redmond 49
Houston 45
Somerville 42
Hanover 41
Ho Chi Minh City 41
New York 41
Toronto 41
Rome 36
Guangzhou 35
Hanoi 35
Lauterbourg 34
Istanbul 33
Sakarya 33
Serra 33
Bengaluru 32
Shanghai 32
Brussels 31
Bogotá 30
Frankfurt am Main 30
Jinan 30
Andover 29
Hefei 29
Buffalo 27
Moscow 26
Abidjan 24
Des Moines 24
Shenyang 24
Cambridge 22
Naples 22
Tianjin 21
Pisa 20
Redwood City 19
Phoenix 18
The Dalles 18
Tokyo 18
Jakarta 16
Seongnam 16
Athens 15
Changsha 15
Columbus 15
Hangzhou 15
Nanchang 15
Eitensheim 14
Helsinki 14
Kent 14
Roxbury 14
Seoul 14
Berlin 13
Medford 12
Ningbo 12
Cangzhou 11
Fuzhou 11
Grafing 11
Hamburg 11
Quanzhou 11
San Diego 11
Atlanta 10
Auckland 10
Nuremberg 10
São Paulo 10
Bitonto 9
Chicago 9
Florence 9
Redondo Beach 9
Turin 9
Brescia 8
Haikou 8
Hebei 8
Lanzhou 8
Palermo 8
Shenzhen 8
Da Nang 7
Warsaw 7
Bari 6
Haiphong 6
Totale 5.193
Nome #
Agonisti nicotinici selettivi nel trattamento di patologie del Sistema Nervoso Centrale 605
Epiboxidine and Novel Related Analogues : a Convenient Synthetic Approach and Estimation of Their Affinity at Neuronal Nicotinic Acetylcholine Receptor Subtypes 524
Atazanavir and lopinavir profile in pregnant women with HIV : tolerability, activity and pregnancy outcomes in an observational national study 363
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region 289
Is "option B+" also being adopted in pregnant women in high-income countries? temporal trends from a national study in Italy 282
New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: Synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations 279
4-Aminoquinoline-statine double drugs 268
Novel biotinylated bile acid amphiphiles: micellar aggregates formation and interaction with hepatocytes 264
A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate 246
Synthesis of gallocatechin-3-gallate analogues 243
PLASMEPSIN II INHIBITION AND ANTIPLASMODIAL ACTIVITY OF PRIMAQUINE-STATINE “DOUBLE-DRUGS” 242
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 241
Antiparasitic activities and toxicities of individual enantiomers of 7-chloro-N-[[(9a)-octahydro-2H-quinolizin-1-yl]methyl]-4-quinolinamine 232
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 224
The enantiomers of epiboxidine and of two related analogs: Synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors 220
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors 215
Epiboxidine and Novel-Related Analogues: A Convenient Synthetic Approach and Estimation of Their at Neuronal Nicotinic Acetylcholine Receptor Subtypes 211
Antiparasitic activity and ADME-tox profile of new 4-aminoquinoline derivatives 210
Parallel synthesis and antileishmanial activity of ether-linked phospholipids 205
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethyl-sulfide bace-1 inhibitors 204
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs' 199
Novel peptidomimetics related to Gonadotropin releasing hormone (GnRH) 196
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethylsulfide BACE-1 inhibitors 192
Design and synthesis of protein–protein interaction mimics as plasmodium falciparum cysteine protease, falcipain-2 inhibitors 192
SYNTHESIS OF ANALOGUES OF GALLOCATECHIN-3-GALLATE AS INHIBITORS OF METALLOPROTEINASE-9 ACTIVITY AND GENE EXPRESSION 186
INHIBITION OF BACE-1 BY HYDROXYETHYLAMINE AND HYDROXYETHYLSULFIDE ISOSTERIC REPLACEMENTS 182
Amino acid derived epoxide ring opening tinder microwave irradiation 182
Alcohols immobilization onto 2-chlorotritylchloridenext term resin under microwave irradiation 177
Identification and screeening of natural and synthetic products with significant antimalarial activity in vitro 176
Inhibition of BACE-1 by hydroxyethylsulfide, hydroxyethylamine and hydroxyethylurea isosteric replacements 175
Selective nicotinic agonists to treat pathologies of the central nervous system 172
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 170
Progettazione e sintesi di analoghi strutturali dell’Epibossodina 161
New Hybrid and Mutant PIA and MII Toxins with Greater Affinty and Selectivity for the A6* Subtype 158
Inhibition of plasmepsin II and IV and antiplasmodial activity of primaquine-statine double drugs 152
Inhibition of Plasmepsins II and IV and Antiplasmodial Activity of Primaquine–Statine Double Drugs 145
Design and synthesis of protein-protein interaction mimics as inhibitors of plasmodium cysteine protease falcipain-2 144
The antimalarial activity of primaquine-statine "double drugs" correlates with the inhibition of plasmepsin II activity 139
Synthetic peptides derived from the C-terminal 6kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development 135
Plasmepsin V, a new promising target for antimalarial drug discovery 123
Totale 8.923
Categoria #
all - tutte 22.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 0 0 37
2021/2022637 73 29 23 33 33 44 82 30 74 49 49 118
2022/2023763 113 74 80 73 92 127 10 70 75 6 36 7
2023/2024497 17 32 38 31 124 29 37 19 13 42 48 67
2024/20251.089 53 124 29 125 101 41 25 100 40 102 112 237
2025/20262.198 223 131 192 161 227 139 255 125 251 195 227 72
Totale 8.923